MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

PharMerica Company Profile (NYSE:PMC)

Consensus Ratings for PharMerica (NYSE:PMC) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $31.83 (36.98% upside)

Analysts' Ratings History for PharMerica (NYSE:PMC)
Show:
DateFirmActionRatingPrice TargetActions
6/7/2016Bank of AmericaInitiated CoverageBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Barrington ResearchReiterated RatingOutperform$30.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Credit SuisseInitiated CoverageOutperform$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016KeyBancLower Price TargetOverweight$39.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016BarclaysLower Price TargetUnderweight$27.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015Cowen and CompanyReiterated RatingBuy$39.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2014Goldman SachsInitiated CoverageNeutral$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Evercore ISIReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for PharMerica (NYSE:PMC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2016        
5/6/2016Q116$0.43$0.45$509.45 million$524.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2016Q415$0.41$0.45$506.40 million$520.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015Q315$0.36$0.39$480.35 million$498.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2015Q215$0.33$0.37$491.66 million$497.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$0.43$0.48$500.95 million$511.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015Q414$0.43$0.45$491.99 million$523.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314$0.40$0.45$439.63 million$470.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.36$0.40$432.70 million$448.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$0.33$0.37$417.76 million$452.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2014Q413$0.38$0.44$421.16 million$433.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$0.32$0.49$398.02 million$442.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2013Q2 2013$0.34$0.44$414.15 million$458.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013$0.34$0.46$435.10 million$439.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2013Q4 2012$0.29$0.12$432.43 million$433.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.30$0.33$446.36 million$442.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$0.30$0.32ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.27$0.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2012$0.21$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011$0.20$0.31ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011$0.20$0.32ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011$0.20$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011$0.17$0.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for PharMerica (NYSE:PMC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.36$0.48$0.41
Q2 20162$0.37$0.46$0.42
Q3 20162$0.38$0.51$0.45
Q4 20162$0.41$0.53$0.47
(Data provided by Zacks Investment Research)
Dividend History for PharMerica (NYSE:PMC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for PharMerica (NYSE:PMC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/2/2015Robert A MckaySVPSell2,993$34.42$103,019.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Mark LindemoenSVPSell3,790$34.71$131,550.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Robert A MckaySVPSell7,000$32.75$229,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Gregory S WeisharCEOSell104,150$32.63$3,398,414.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Mark LindemoenSVPSell4,500$33.27$149,715.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Berard TomassettiCAOSell3,344$26.44$88,415.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Thomas A CanerisSVPSell7,495$26.52$198,767.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Robert A MckaySVPSell20,000$26.74$534,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2014Robert A OakleyDirectorSell8,399$26.55$222,993.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Thomas CanerisSVPSell12,192$28.60$348,691.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014Gregory WeisharCEOSell60,000$26.27$1,576,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2014Robert MckaySVPSell18,646$26.08$486,287.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2014Berard TomassettiCAOSell3,812$25.22$96,138.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014Thomas CanerisSVPSell14,357$25.60$367,539.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/22/2013Thomas GerrityDirectorSell3,271$20.56$67,251.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Berard TomassettiCAOSell4,097$20.55$84,193.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2013Berard TomassettiCAOSell9,724$15.68$152,472.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for PharMerica (NYSE:PMC)
DateHeadline
06/22/16 08:30 AMZacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival -
06/21/16 03:08 PMPHARMERICA CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/15/16 07:40 AMWhy the Earnings Streak Will Continue for PharMerica (PMC) -
06/14/16 10:40 AMPharmerica Corporation (PMC) - Financial and Strategic SWOT Analysis Review - New Market Research Report
06/13/16 07:22 AMHedge Funds’ Favorite Stocks With Low Price-to-Cash-Flow Ratios -
06/07/16 07:42 AMSurging Earnings Estimates Signal Good News for PharMerica (PMC) -
06/03/16 06:24 PMPharmerica Corporation (NYSE:PMC) Price Target and Stock Rating Synopsis
05/23/16 11:46 AMIs PharMerica Corporation (PMC) a Good Stock to Buy? -
05/17/16 10:50 AMPharMerica wants the Supreme Court to rethink this decision -
05/17/16 07:42 AMPharMerica to Present at the UBS Global HealthCare Conference - [at noodls] - LOUISVILLE, Ky.--(BUSINESS WIRE)--May 17, 2016-- PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, and oncology pharmacy services, today announced that Gregory ...
05/13/16 08:05 AMPharmerica's growth strategy is really generic -
05/12/16 10:26 AMPharMerica Corp. :PMC-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/06/16 01:20 PMPharMerica's 1Q earnings fell sharply but beat expectations -
05/06/16 10:07 AMEdited Transcript of PMC earnings conference call or presentation 6-May-16 2:00pm GMT -
05/06/16 07:24 AMPharMerica Reports First Quarter 2016 Results - [at noodls] - Financial Results Exceed Expectations Strong Cash Flow From Operating Activities Industry Leading Generic Dispensing Rate Increases to Record 86.6% Reaffirms Annual 2016 Guidance LOUISVILLE, Ky.--(BUSINESS ...
05/06/16 07:08 AMPharMerica beats 1Q profit forecasts -
04/20/16 10:39 AMPharMerica Corp. – Value Analysis (NYSE:PMC) : April 20, 2016 -
04/19/16 07:07 AMPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : April 19, 2016 -
04/12/16 03:26 PMPharMerica Corporation Announces First Quarter 2016 Earnings Call and Webcast - [at noodls] - LOUISVILLE, Ky.--(BUSINESS WIRE)--Apr. 12, 2016-- PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its first quarter 2016 earnings conference call on Friday, ...
04/04/16 03:51 PMPHARMERICA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
04/02/16 01:42 PMPharmerica Corp (NYSE:PMC) Sentiment Improved, Despite Downtrend - RiversideGazette.com - Pharmerica Corp (NYSE:PMC) Sentiment Improved, Despite DowntrendRiversideGazette.comAlso, the number of active investment managers holding Pharmerica Corp in their top 10 equity positions decreased from 3 to 2 for a decrease of 1. Sold All: 16 Reduced: 61 Increased: 60 New Position: 27. PharMerica Corporation is an institutional ...Stock Earnings in Review: PharMerica Corporation (NYSE:PMC)CWRU ObserverFresh: How did Barclays Capital rate Pharmerica Corp.?The Duncan Independent (press release) (blog)all 3 news articles »
03/29/16 03:36 PMPharMerica Announces Date of 2016 Annual Meeting of Shareholders - [at noodls] - LOUISVILLE, Ky.--(BUSINESS WIRE)--Mar. 29, 2016-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today announced ...
03/29/16 10:04 AMETF’s with exposure to PharMerica Corp. : March 29, 2016 -
03/24/16 12:40 PMPharMerica execs could get big bonus checks -
03/23/16 04:03 PMPHARMERICA CORP Files SEC form 8-K, Change in Directors or Principal Officers -
03/14/16 08:29 AMPharMerica downgraded by UBS -
03/12/16 02:01 PMPharmerica Corporation Common S (PMC) Hits a New 52-Week Low - Stock prices of Pharmerica Corporation Common S (NYSE:PMC) exerienced a new one year low price reaching $20.21 on Thursday. The company traded down with a change of $0.67 ending the day at $20.74. Volume was 508,860 shares and the stock hit a high of $21.64.
03/07/16 11:53 AMPharMerica Corp. :PMC-US: Earnings Analysis: Q4, 2015 By the Numbers -
03/02/16 04:28 PMPHARMERICA CORP Files SEC form 8-K, Other Events -
02/29/16 07:35 AMPharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : February 29, 2016 -
02/28/16 12:59 PMPharMerica's (PMC) CEO Greg Weishar on Q4 2015 Results - Earnings Call Transcript - Welcome to the PharMerica Corporation Q4 2015 Earnings Conference Call. [Operator Instructions]. I would now like to introduce your host for today's conference, Mr. Berard Tomassetti, Senior Vice President and Chief Accounting Officer. Sir, you may begin.
02/28/16 09:40 AM5 Health Care Stocks John Paulson Is Betting On for 2016 -
02/26/16 12:00 PMEdited Transcript of PMC earnings conference call or presentation 26-Feb-16 3:00pm GMT -
02/26/16 09:00 AMPharMerica Corp Earnings Call scheduled for 10:00 am ET today -
02/26/16 08:04 AMShifting 'tectonic plates' pause PharMerica whistleblower suit - Louisville Business First - Louisville Business FirstShifting 'tectonic plates' pause PharMerica whistleblower suitLouisville Business FirstA dismissed, then revived whistleblower lawsuit against Louisville-based PharMerica Corp. is now on hold. The suit was originally filed in 2010 by former PharMerica pharmacist Robert Gadbois, who accused the company (NYSE: PMC) of overbilling ...
02/26/16 08:04 AMCompany Earnings Report, Feb. 26 - PharMerica Corporation (PMC) – – The company is estimated to post its earnings for the current quarter at $0.41 a share on $506.40 million sales. Rowan Companies PLC (RDC) – – The company is seen to post its earnings for the current quarter at $0 ...
02/26/16 07:17 AMPharMerica beats 4Q profit forecasts -
02/26/16 07:02 AMPHARMERICA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
02/26/16 07:02 AM8:02 am PharMerica beats by $0.04, beats on revs; guides FY16 EPS below consensus, revs in-line -
02/26/16 07:00 AMPharMerica Reports Fourth Quarter and Full Year 2015 Results - [Business Wire] - PharMerica Corporation , a diversified national provider of institutional and specialty pharmacy services, today reported its financial results for the fourth quarter and full year ended December 31, 2015.
02/26/16 06:07 AMQ4 2015 PharMerica Corp Earnings Release - Before Market Open -
02/25/16 01:20 PMShifting 'tectonic plates' pause PharMerica whistleblower suit -
02/23/16 01:27 PMWhat's PharMerica Corporation Upside After Today's Gap Up? - RiversideGazette.com - What's PharMerica Corporation Upside After Today's Gap Up?RiversideGazette.comThe stock of PharMerica Corporation (NYSE:PMC) gapped up by $0.21 today and has $36.27 target or 23.00% above today's $29.49 share price. The 9 months technical chart setup indicates low risk for the $904.98 million company. The gap was reported on ...and more »
02/12/16 12:09 PMKennedy Capital Management Inc Increased Greatbatch Inc (NYSE:GB) by $10.09 Million as Shares Declined - WallStreet.org - Kennedy Capital Management Inc Increased Greatbatch Inc (NYSE:GB) by $10.09 Million as Shares DeclinedWallStreet.orgKennedy Capital Management Inc, which manages about $5.67B and $4.94 billion US Long portfolio, decreased its stake in Pharmerica Corporation (NYSE:PMC) by 485,525 shares to 230,637 shares, valued at $8.07M in Q4, according to the filing. ... Moreover ...and more »
02/12/16 12:09 PMPharmerica Corporation (NYSE:PMC) Turns Into Buzzing Stock - Stocks Daily - Pharmerica Corporation (NYSE:PMC) Turns Into Buzzing StockStocks DailyApart from ratings, the brokerages have issued price projections on the company's stock. As per the estimates, the one-year price target on Pharmerica Corporation (NYSE:PMC) stands at $37.166. They have also set the price target range, as per which ...and more »
02/12/16 12:09 PMAirain Ltd Increased Pharmerica Corp (NYSE:PMC) by $13.29 Million as Shares Rose - The stock is down 0.79% or $0.22 hitting $27.53, despite the positive news. About 96,625 shares traded hands. PharMerica Corporation (NYSE:PMC) has declined 19.57% since July 8, 2015 and is downtrending. It has underperformed by 10.05% the S&P500.
02/11/16 12:03 PMHottest Retail Trade Stocks Now – GFN HBI PMC OLLI - Investorplace.com - Hottest Retail Trade Stocks Now – GFN HBI PMC OLLIInvestorplace.comPharmerica Corp (PMC): PMC stock is down 0.58% today. Ollie's Bargain Outlet Holdings (OLLI): OLLI stock is down 0.25% ... The Wendy's Company (WEN): WEN stock is down 4.52% today. Good Times Restaurants Inc (GTIM): GTIM stock is down 8.29% ...
02/09/16 11:40 AMPharmerica Corporation (NYSE:PMC) Earnings Alert - Investor Newswire - Pharmerica Corporation (NYSE:PMC) Earnings AlertInvestor NewswireGoing further, there is no shortfall of market views coming from the experts on the price target and earnings expectations of the company. As per them, Pharmerica Corporation (NYSE:PMC) has a mean price target of $37.166 on its stock. Analysts with a ...and more »
02/09/16 07:00 AMPharMerica Corporation Announces Fourth Quarter and Year-End 2015 Earnings Call and Webcast - [Business Wire] - PharMerica Corporation announced today that it will provide an online webcast of its fourth quarter and year-end 2015 earnings conference call on Friday, February 26, 2016.
02/05/16 11:20 AMAnalyst Coverage Updates - Pharmerica Corporation (NYSE:PMC) - Risers & Fallers - Analyst Coverage Updates - Pharmerica Corporation (NYSE:PMC)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Pharmerica Corporation (NYSE:PMC). The latest broker reports which are currently outstanding on Friday 5th February state 1 analyst has a rating of “strong buy”, 4 ...and more »
About PharMerica

PharMerica logoPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.

Industry, Sector and Symbol:
  • Sector: Services
  • Industry: Drug Stores
  • Sub-Industry: Health Care Distributors
  • Exchange: NYSE
  • Symbol: PMC
  • CUSIP: 71714F10
Key Metrics:
  • Previous Close: $23.24
  • 50 Day Moving Average: $25.86
  • 200 Day Moving Average: $26.39
  • P/E Ratio: 24.21
  • P/E Growth: 1.22
  • Market Cap: $714.26M
  • Current Quarter EPS Consensus Estimate: $2.02 EPS
Additional Links:
PharMerica (NYSE:PMC) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha